enVVeno Medical Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Robert A. Berman, with a market cap of $6.9M.
Upcoming earnings announcement for enVVeno Medical Corporation
Past 12 earnings reports for enVVeno Medical Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$6.05Est: -$0.28 | -2060.7% | - | — | |
| Oct 31, 2025 | Q3 2025 | -$0.23Est: -$0.30 | +23.3% | - | — | |
| May 1, 2025 | Q1 2025 | -$0.22Est: -$0.34 | +35.3% | - | — | |
| Feb 28, 2025 | Q4 2024 | -$0.30Est: -$0.35 | +14.3% | - | — | |
| Oct 31, 2024 | Q3 2024 | -$0.35Est: -$0.33 | -6.1% | - | — | |
| Jul 31, 2024 | Q2 2024 | -$0.31Est: -$0.36 | +13.9% | - | — | |
| May 8, 2024 | Q1 2024 | -$0.31Est: -$0.40 | +22.5% | - | — | |
| Feb 29, 2024 | Q4 2023 | -$0.32Est: -$0.46 | +30.4% | - | — | |
| Oct 26, 2023 | Q3 2023 | -$0.54Est: -$0.48 | -12.5% | - | — | — |
| Jul 31, 2023 | Q2 2023 | -$0.58Est: -$0.49 | -18.4% | - | — | — |
| May 1, 2023 | Q1 2023 | -$0.57 | — | - | — | — |
| Mar 2, 2023 | Q4 2022 | -$0.55 | — | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.